MY ACCOUNT | NEWSLETTER |

Legacy fuels UWVC leadership in comprehensive cancer care

New university findings highlight potential implications for dogs, oncology, and veterinary practice.


“By bringing exceptional veterinarians and scientists together, we’re creating new possibilities for patients through cutting-edge clinical trials and treatments — momentum we will build on for years to come.” UWVC is one of just a handful of animal hospitals in the United States that is home to medical, radiation, and surgical oncologists, which means patients and their families have access to a wider range of treatment information and options than if they were being seen by a single specialty.

For 40 years, the UW School of Veterinary Medicine (SVM) and UW Veterinary Care (UWVC) have been leaders in veterinary oncology.

From the development of advanced radiation treatments to testing anti-cancer vaccines, UW Vet Med clinicians have long been on the front lines of redefining how cancer is treated.

Today, the school continues to build on that legacy, bringing together medical, radiation, and surgical oncologists to form a comprehensive oncology service providing cancer care that is unmatched in Wisconsin and the upper Midwest.

“Our drive to revolutionize cancer care is unwavering,” says Dean Jon Levine .

And there is a pressing need for care — roughly 25% of dogs and 20% of cats will be diagnosed with cancer in their lifetimes.

The hospital’s comprehensive approach to cancer care — and its culture of collaboration across services — augments the ability of UWVC clinicians to treat the disease, says medical oncologist MacKenzie Pellin (’06 DVM’11; Dept.

Traditionally the entry point for most patients at UWVC, medical oncology is one pillar in the full spectrum of care from a unified, comprehensive care team.

“Now, radiation and surgical oncology see cases with us,” Pellin says.

“We all work together, and our integrated approach provides the best care possible for patients.” The importance of collaboration is underscored by earlier successes: The team made pioneering breakthroughs in radiation oncology, such as a now-widely used protocol for cardiac hemangiosarcoma — an aggressive cancer of blood vessels that affects the heart.

“It hadn’t been commonplace to use radiation for that, but we created a safe protocol and combined it with novel chemotherapy,” says radiation oncologist Michelle Turek (Dept.

The report adds to ongoing university-led research relevant to veterinary medicine, animal health, and clinical decision-making.

Source university website: University of Wisconsin School of Veterinary Medicine

https://www.vetmed.wisc.edu/legacy-fuels-uwvc-leadership-in-comprehensive-cancer-care/

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

DNA My Dog Expands Product Suite With Launch of New Health and Trait Test, Building on 18-Year Foundation in Canine Genetic Testing

Like0
Dislike0

From companion animals to patients interspecies lessons in neuroendocrine oncology.

Like0
Dislike0

Clinical signs, management, and survival of 278 dogs diagnosed with insulinoma under primary veterinary care in the United Kingdom.

Like0
Dislike0

Comparative evaluation of a novel phytochemical mixture and monensin on host- and pathogen-targeted strategies in broiler chickens challenged with Eimeria maxima.

Like0
Dislike0

Clinical Trials • College News • Research Ohio State Launches Clinical Trial for Promising New Treatment for Acu...

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top